scispace - formally typeset
P

Patrick J. Bednarski

Researcher at University of Greifswald

Publications -  118
Citations -  8461

Patrick J. Bednarski is an academic researcher from University of Greifswald. The author has contributed to research in topics: Cisplatin & Bicyclic molecule. The author has an hindex of 29, co-authored 112 publications receiving 7642 citations. Previous affiliations of Patrick J. Bednarski include Gdańsk Medical University.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Photoactivatable platinum complexes.

Patrick J. Bednarski, +2 more
- 01 Jan 2007 - 
TL;DR: These studies show that photoactivatable Pt(IV) antitumor agents represent a promising area for new drug development and are stable to glutathione and thus show very low dark cytotoxicity.
Journal ArticleDOI

Studies of the in vitro anticancer, antimicrobial and antioxidant potentials of selected Yemeni medicinal plants from the island Soqotra

Ramzi A. Mothana, +3 more
- 25 Mar 2009 - 
TL;DR: The results show once again that medicinal plants can be promising sources of natural products with potential anticancer, antimicrobial and antioxidative activity.
Journal ArticleDOI

Structure–Activity Relationships of Targeted RuII(η6-p-Cymene) Anticancer Complexes with Flavonol-Derived Ligands

Andrea Kurzwernhart, +14 more
- 19 Nov 2012 - 
TL;DR: Compared to the flavonol ligands, the RuII(η6-p-cymene) complexes are more potent antiproliferative agents, which can be explained by potential multitargeted properties.
Journal ArticleDOI

Novel C,N-Cyclometalated Benzimidazole Ruthenium(II) and Iridium(III) Complexes as Antitumor and Antiangiogenic Agents: A Structure–Activity Relationship Study

Jyoti G. Yellol, +10 more
- 04 Sep 2015 - 
TL;DR: Phenyl substitution at the R4 position shows increased potency in both Ru and Ir complexes as compared to their parent compounds (3a and 4a) in all cell lines, and in general, ruthenium complexes are more active than the corresponding iridium complexes.